Cargando…
Genistein inhibits the S-phase kinase-associated protein 2 expression in breast cancer cells
Breast cancer is one of the most lethal cancers affecting women worldwide and was estimated to account for ~30% of all new cancer diagnoses in women. Although available evidence has proved the tumor suppressor role of genistein in cancer, the underling mechanisms have remained to be fully elucidated...
Autores principales: | Ye, Dengfeng, Li, Zhian, Wei, Chunshou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772955/ https://www.ncbi.nlm.nih.gov/pubmed/29434697 http://dx.doi.org/10.3892/etm.2017.5489 |
Ejemplares similares
-
Magnetic resonance imaging in screening women at high risk of breast cancer: A meta-analysis
por: Ding, Wu, et al.
Publicado: (2023) -
Genistein-induced mir-23b expression inhibits the growth of breast cancer cells
por: Avci, Cigir Biray, et al.
Publicado: (2014) -
Mechanism of Inhibition of Cyclic Nucleotide–Gated Channel by Protein Tyrosine Kinase Probed with Genistein
por: Molokanova, Elena, et al.
Publicado: (2001) -
Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation
por: ZHANG, LING, et al.
Publicado: (2015) -
Noncatalytic Inhibition of Cyclic Nucleotide–gated Channels by Tyrosine Kinase Induced by Genistein
por: Molokanova, Elena, et al.
Publicado: (1999)